Supriya Lifescience Limited has intimated the stock exchanges about an upcoming earnings call to discuss the company's operational and financial performance for the first quarter of fiscal year 2027 (Q1 FY27), ended June 30, 2026.
The earnings call is scheduled for Friday, August 14, 2026, at 11:00 AM Indian Standard Time (IST).
The management representatives who will participate in the call include:
- Dr. Satish Wagh, Executive Chairman & Whole Time Director
- Dr. Saloni Wagh, Managing Director
- Mr. Krishna Raghunathan, Chief Financial Officer
The communication includes dial-in access numbers for participants from various regions:
- Primary Numbers: +91 22 6280 1107, +91 22 7115 8008
- Hongkong: 800 964 448
- Singapore: 800 101 2045
- USA: 1866 746 2133
- UK: 0808 101 1573
The company noted that an investor presentation will be shared with the exchanges separately from this intimation.
The letter was digitally signed by Prachi Suhas Sathe, Company Secretary & Compliance Officer, on August 10, 2026, at 21:28:04 IST.
Company contact information provided includes:
- Corporate Office: 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063, Maharashtra, India
- Factory: A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin: 415 722, Maharashtra, India
- GSTIN: 27AALCS8686A1ZX
Investor relations contacts from EY are mentioned as Runjhun Jain and Sneha Salian with their respective email addresses.